Current and historical daily PE Ratio for Verastem Inc (
) from 2012 to Jun 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Verastem stock (FRA:2VSA) PE ratio as of Jun 21 2024 is 0.
More Details
Verastem Inc (FRA:2VSA) PE Ratio (TTM) Chart
Verastem Inc (FRA:2VSA) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1290
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Verastem PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-22 | At Loss | 2024-04-18 | At Loss |
2024-06-20 | At Loss | 2024-04-17 | At Loss |
2024-06-19 | At Loss | 2024-04-16 | At Loss |
2024-06-18 | At Loss | 2024-04-15 | At Loss |
2024-06-17 | At Loss | 2024-04-12 | At Loss |
2024-06-14 | At Loss | 2024-04-11 | At Loss |
2024-06-13 | At Loss | 2024-04-10 | At Loss |
2024-06-12 | At Loss | 2024-04-09 | At Loss |
2024-06-11 | At Loss | 2024-04-08 | At Loss |
2024-06-10 | At Loss | 2024-04-05 | At Loss |
2024-06-07 | At Loss | 2024-04-04 | At Loss |
2024-06-06 | At Loss | 2024-04-03 | At Loss |
2024-06-05 | At Loss | 2024-04-02 | At Loss |
2024-06-04 | At Loss | 2024-03-28 | At Loss |
2024-06-03 | At Loss | 2024-03-27 | At Loss |
2024-05-31 | At Loss | 2024-03-26 | At Loss |
2024-05-30 | At Loss | 2024-03-25 | At Loss |
2024-05-29 | At Loss | 2024-03-22 | At Loss |
2024-05-28 | At Loss | 2024-03-21 | At Loss |
2024-05-27 | At Loss | 2024-03-20 | At Loss |
2024-05-24 | At Loss | 2024-03-19 | At Loss |
2024-05-23 | At Loss | 2024-03-18 | At Loss |
2024-05-22 | At Loss | 2024-03-15 | At Loss |
2024-05-21 | At Loss | 2024-03-14 | At Loss |
2024-05-20 | At Loss | 2024-03-13 | At Loss |
2024-05-17 | At Loss | 2024-03-12 | At Loss |
2024-05-16 | At Loss | 2024-03-11 | At Loss |
2024-05-15 | At Loss | 2024-03-08 | At Loss |
2024-05-14 | At Loss | 2024-03-07 | At Loss |
2024-05-13 | At Loss | 2024-03-06 | At Loss |
2024-05-10 | At Loss | 2024-03-05 | At Loss |
2024-05-09 | At Loss | 2024-03-04 | At Loss |
2024-05-08 | At Loss | 2024-03-01 | At Loss |
2024-05-07 | At Loss | 2024-02-29 | At Loss |
2024-05-06 | At Loss | 2024-02-28 | At Loss |
2024-05-03 | At Loss | 2024-02-27 | At Loss |
2024-05-02 | At Loss | 2024-02-26 | At Loss |
2024-04-30 | At Loss | 2024-02-23 | At Loss |
2024-04-29 | At Loss | 2024-02-22 | At Loss |
2024-04-26 | At Loss | 2024-02-21 | At Loss |
2024-04-25 | At Loss | 2024-02-20 | At Loss |
2024-04-24 | At Loss | 2024-02-19 | At Loss |
2024-04-23 | At Loss | 2024-02-16 | At Loss |
2024-04-22 | At Loss | 2024-02-15 | At Loss |
2024-04-19 | At Loss | 2024-02-14 | At Loss |
Verastem Inc (FRA:2VSA) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Verastem Inc Verastem Inc logo](https://static.gurufocus.com/logos/0C000093E9.png?14)
Verastem Inc
NAICS : 325412
SIC : 2834
ISIN : US92337C1045
Description
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.